U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07179341) titled 'Survival Nomogram for Patients With Thymic Carcinoma' on Sept. 04.
Brief Summary: Background Thymic carcinoma (TC) is a rare and aggressive mediastinal malignancy with poor prognosis. Our study aimed to develop a nomogram to predict overall survival (OS) of TC patients.
Method A total of 156 patients confirmed TC between 1996 and 2023 were selected from our database. They were divided into training cohort, validation cohort one and validation cohort two. A nomogram was constructed based on the risk factors affecting prognosis using a Cox proportional hazards regression model. The discrimination and calibration of the nomogram were...